Cargando…

Adherence to Antihypertensive Medication in Treatment‐Resistant Hypertension Undergoing Renal Denervation

BACKGROUND: Adherence to medication has been repeatedly proposed to represent a major cause of treatment‐resistant hypertension (TRH); however, treatment decisions such as treating TRH with renal denervation depend on accurate judgment of adherence. We carefully analyzed adherence rates to medicatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmieder, Roland E., Ott, Christian, Schmid, Axel, Friedrich, Stefanie, Kistner, Iris, Ditting, Tilmann, Veelken, Roland, Uder, Michael, Toennes, Stefan W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802436/ https://www.ncbi.nlm.nih.gov/pubmed/26873693 http://dx.doi.org/10.1161/JAHA.115.002343

Ejemplares similares

Responsiveness of afferent renal nerve units in renovascular hypertension in rats
por: Rodionova, Kristina, et al.
Publicado: (2021)

Poor Glycemic Control Is Related to Increased Nitric Oxide Activity Within the Renal Circulation of Patients With Type 2 Diabetes
por: Schneider, Markus P., et al.
Publicado: (2013)

Myocardial infarction with a preserved ejection fraction—the impaired function of the cardio-renal baroreflex
por: Pickny, Lisa, et al.
Publicado: (2023)

Editorial comment: Renal denervation
por: Schmieder, Roland E., et al.
Publicado: (2021)

Neurogenic tachykinin mechanisms in experimental nephritis of rats
por: Rodionova, Kristina, et al.
Publicado: (2020)

Afferent neurons of the kidney with impaired firing pattern in inflammation – role of sodium currents?
por: Lale, Nena, et al.
Publicado: (2023)

Retinal capillary rarefaction in patients with untreated mild-moderate hypertension
por: Bosch, Agnes J., et al.
Publicado: (2017)

Renal Denervation: A Practical Guide for Health Professionals Managing Hypertension
por: Schmieder, Roland, et al.
Publicado: (2023)

Neurogenic substance P—influences on action potential production in afferent neurons of the kidney?
por: Rodionova, Kristina, et al.
Publicado: (2021)

Retinal Capillary Rarefaction in Patients with Type 2 Diabetes Mellitus
por: Jumar, Agnes, et al.
Publicado: (2016)

Adherence to antihypertensive medication in renal denervation trials: new studies, old problems?
por: Lauder, Lucas, et al.
Publicado: (2023)

Renal denervation in patients with chronic kidney disease: current evidence and future perspectives
por: Schmieder, Roland E
Publicado: (2022)

Differences in patient and physician perspectives on pharmaceutical therapy and renal denervation for the management of hypertension
por: Schmieder, Roland E., et al.
Publicado: (2021)

Screening for non-adherence to antihypertensive treatment as a part of the diagnostic pathway to renal denervation
por: Patel, P, et al.
Publicado: (2016)

Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINE
por: Mahfoud, Felix, et al.
Publicado: (2023)

New data, new studies, new hopes for renal denervation in patients with uncontrolled hypertension
por: Papademetriou, Vasilios, et al.
Publicado: (2019)

Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes
por: Ott, Christian, et al.
Publicado: (2014)

Renal denervation in the antihypertensive arsenal – knowns and known unknowns
por: Messerli, Franz H., et al.
Publicado: (2023)

Renal denervation in hypertensive patients not on blood pressure lowering drugs
por: De Jager, Rosa L., et al.
Publicado: (2016)

Changes in 24-Hour Patterns of Blood Pressure in Hypertension Following Renal Denervation Therapy
por: Kario, Kazuomi, et al.
Publicado: (2019)

Reproducibility of Kidney Perfusion Measurements With Arterial Spin Labeling at 1.5 Tesla MRI Combined With Semiautomatic Segmentation for Differential Cortical and Medullary Assessment
por: Hammon, Matthias, et al.
Publicado: (2016)

Long-Term Safety and Antihypertensive Effects of Renal Denervation: Current Insights
por: Reyes, Klevin Roger L, et al.
Publicado: (2023)

Adherence to Antihypertensive Medication in Older Adults With Hypertension
por: Lo, Suzanne H. S., et al.
Publicado: (2016)

Safety and Efficacy of a New Renal Denervation Catheter in Hypertensive Patients in the Absent of Antihypertensive Medications: A Pilot Study
por: Li, Yang, et al.
Publicado: (2019)

Renal Sympathetic Denervation for Hypertension
por: Guber, Kenneth, et al.
Publicado: (2022)

Renal denervation for uncontrolled hypertension
por: Marcusohn, Erez, et al.
Publicado: (2023)

Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design
por: Böhm, Michael, et al.
Publicado: (2020)

Correction to: Rationale and design of two randomized sham‑controlled of catheter‑based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN‑OFF MED Pivotal) and presence (SPYRAL HTN‑ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design
por: Böhm, Michael, et al.
Publicado: (2020)

Executive Summary of the Joint Position Paper on Renal Denervation of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) and the European Society of Hypertension (ESH)
por: Moss, Jonathan G., et al.
Publicado: (2016)

Evaluation of the dose-related concentration approach in therapeutic drug monitoring of diuretics and β-blockers – drug classes with low adherence in antihypertensive therapy
por: Ritscher, Sabrina, et al.
Publicado: (2019)

Benefit of serum drug monitoring complementing urine analysis to assess adherence to antihypertensive drugs in first-line therapy
por: Ritscher, Sabrina, et al.
Publicado: (2020)

Identifying poor adherence to antihypertensive medications in patients with resistant hypertension
por: Mackenzie, Isla S., et al.
Publicado: (2018)

The Implementation of Renal Denervation in the Management of Resistant Hypertension Despite Use of Multitherapy Antihypertensives at Maximally Tolerated Doses: A Contemporary Literature Review
por: Obi, Mukosolu F, et al.
Publicado: (2023)

Renal denervation as an option for the management of hypertension
por: Santiapillai, Georgina Radhini, et al.
Publicado: (2014)

Renal denervation for the management of resistant hypertension
por: Patel, Hitesh C, et al.
Publicado: (2015)

Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant Hypertension
por: Mahfoud, Felix, et al.
Publicado: (2021)

Put Your Lights On: Electrocution As a Cause of an Unexplained Fall and Loss of Consciousness
por: Grzesiek, Magdalena, et al.
Publicado: (2019)

Treating resistant hypertension: role of renal denervation
por: Urban, Daniel, et al.
Publicado: (2013)

Is isolated systolic hypertension an indication for renal denervation?
por: Wang, Yutang
Publicado: (2014)

Renal Sympathetic Denervation in the Treatment of Resistant Hypertension
por: Sánchez-Álvarez, Catalina, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qrh3d9lsmdhm3naa5baqg7gs25